Correlation Between Blueprint Medicines and Day One
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Blueprint Medicines and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Day One.
Diversification Opportunities for Blueprint Medicines and Day One
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Blueprint and Day is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Day One go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Day One
Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 1.64 times more return on investment than Day One. However, Blueprint Medicines is 1.64 times more volatile than Day One Biopharmaceuticals. It trades about 0.32 of its potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about 0.06 per unit of risk. If you would invest 8,720 in Blueprint Medicines Corp on November 2, 2024 and sell it today you would earn a total of 2,685 from holding Blueprint Medicines Corp or generate 30.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Day One Biopharmaceuticals
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Day One Biopharmaceu |
Blueprint Medicines and Day One Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Day One
The main advantage of trading using opposite Blueprint Medicines and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
| Day One vs. Surrozen | Day One vs. Armata Pharmaceuticals | Day One vs. Pasithea Therapeutics Corp | Day One vs. Aditxt Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |